{"entity":{"type":"insider","cik":"0001586892","url":"/insider/0001586892","json_url":"/insider/0001586892.json","name":"Shoemaker Daniel D","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":31,"n_filings":11,"first":"2014-04-02","last":"2021-03-09","span_basis":"filed_date"},"name_variants":[{"name":"Shoemaker Daniel D","source":"filing","n_filings":11,"first_seen":"2014-04-02","last_seen":"2021-03-09"}],"transactions":[{"id":4330777,"accession":"0001209191-21-018932","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-21-018932","line_url":"/filing/0001209191-21-018932","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586892","owner_name":"Shoemaker Daniel D","owner_display_name":"Shoemaker Daniel D","owner_url":"/insider/0001586892","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":81.737129552,"price_display":"81.74","price_state":"stated","total_value":2043428.2388,"total_display":"2,043,428.24","total_whole":"2,043,428","shares_owned_after":84921.0,"shares_owned_after_display":"84,921","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-08","filed_date":"2021-03-09","scope":"insider","n_lines":8},{"id":4881319,"accession":"0001209191-21-003338","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-21-003338","line_url":"/filing/0001209191-21-003338","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586892","owner_name":"Shoemaker Daniel D","owner_display_name":"Shoemaker Daniel D","owner_url":"/insider/0001586892","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3253.0,"shares_display":"3,253","price_per_share":110.81372456194282,"price_display":"110.81","price_state":"stated","total_value":360477.046,"total_display":"360,477.05","total_whole":"360,477","shares_owned_after":85530.0,"shares_owned_after_display":"85,530","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-11","filed_date":"2021-01-12","scope":"insider","n_lines":3},{"id":4881306,"accession":"0001209191-21-003338","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-003338","line_url":"/filing/0001209191-21-003338","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586892","owner_name":"Shoemaker Daniel D","owner_display_name":"Shoemaker Daniel D","owner_url":"/insider/0001586892","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6229.0,"shares_display":"6,229","price_per_share":117.10297511639108,"price_display":"117.10","price_state":"stated","total_value":729434.432,"total_display":"729,434.43","total_whole":"729,434","shares_owned_after":90336.0,"shares_owned_after_display":"90,336","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-08","filed_date":"2021-01-12","scope":"insider","n_lines":4},{"id":2659074,"accession":"0001209191-20-058492","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-058492","line_url":"/filing/0001209191-20-058492","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586892","owner_name":"Shoemaker Daniel D","owner_display_name":"Shoemaker Daniel D","owner_url":"/insider/0001586892","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":51.829828236,"price_display":"51.83","price_state":"stated","total_value":1295745.7059,"total_display":"1,295,745.71","total_whole":"1,295,746","shares_owned_after":93091.0,"shares_owned_after_display":"93,091","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-16","filed_date":"2020-11-16","scope":"insider","n_lines":3},{"id":3199794,"accession":"0001209191-20-050681","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-050681","line_url":"/filing/0001209191-20-050681","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586892","owner_name":"Shoemaker Daniel D","owner_display_name":"Shoemaker Daniel D","owner_url":"/insider/0001586892","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":36.301582416,"price_display":"36.30","price_state":"stated","total_value":907539.5604,"total_display":"907,539.56","total_whole":"907,540","shares_owned_after":123804.0,"shares_owned_after_display":"123,804","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-14","filed_date":"2020-09-16","scope":"insider","n_lines":3},{"id":2757543,"accession":"0001209191-20-003025","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-003025","line_url":"/filing/0001209191-20-003025#line-2","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586892","owner_name":"Shoemaker Daniel D","owner_display_name":"Shoemaker Daniel D","owner_url":"/insider/0001586892","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5700.0,"shares_display":"5,700","price_per_share":20.6993,"price_display":"20.70","price_state":"stated","total_value":117986.01,"total_display":"117,986.01","total_whole":"117,986","shares_owned_after":143091.0,"shares_owned_after_display":"143,091","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-08","filed_date":"2020-01-10","scope":"insider"},{"id":2576236,"accession":"0001209191-20-000242","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-000242","line_url":"/filing/0001209191-20-000242","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586892","owner_name":"Shoemaker Daniel D","owner_display_name":"Shoemaker Daniel D","owner_url":"/insider/0001586892","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":19.4970852,"price_display":"19.50","price_state":"stated","total_value":487427.13,"total_display":"487,427.13","total_whole":"487,427","shares_owned_after":123891.0,"shares_owned_after_display":"123,891","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-30","filed_date":"2020-01-02","scope":"insider","n_lines":2},{"id":8102611,"accession":"0001209191-19-053272","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-053272","line_url":"/filing/0001209191-19-053272#line-1","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586892","owner_name":"Shoemaker Daniel D","owner_display_name":"Shoemaker Daniel D","owner_url":"/insider/0001586892","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11800.0,"shares_display":"11,800","price_per_share":14.2875,"price_display":"14.29","price_state":"stated","total_value":168592.5,"total_display":"168,592.50","total_whole":"168,593","shares_owned_after":123791.0,"shares_owned_after_display":"123,791","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-10-15","filed_date":"2019-10-16","scope":"insider"},{"id":8646665,"accession":"0001209191-19-039461","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-039461","line_url":"/filing/0001209191-19-039461#line-2","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586892","owner_name":"Shoemaker Daniel D","owner_display_name":"Shoemaker Daniel D","owner_url":"/insider/0001586892","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":20.2088,"price_display":"20.21","price_state":"stated","total_value":252610.0,"total_display":"252,610.00","total_whole":"252,610","shares_owned_after":135591.0,"shares_owned_after_display":"135,591","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-06-27","filed_date":"2019-06-28","scope":"insider"},{"id":8616186,"accession":"0001209191-19-021717","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-021717","line_url":"/filing/0001209191-19-021717#line-2","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586892","owner_name":"Shoemaker Daniel D","owner_display_name":"Shoemaker Daniel D","owner_url":"/insider/0001586892","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12500.0,"shares_display":"12,500","price_per_share":16.9362,"price_display":"16.94","price_state":"stated","total_value":211702.5,"total_display":"211,702.50","total_whole":"211,703","shares_owned_after":135591.0,"shares_owned_after_display":"135,591","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-03-28","filed_date":"2019-03-29","scope":"insider"},{"id":4423137,"accession":"0001209191-17-057147","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-17-057147","line_url":"/filing/0001209191-17-057147#line-2","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586892","owner_name":"Shoemaker Daniel D","owner_display_name":"Shoemaker Daniel D","owner_url":"/insider/0001586892","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":4.08,"price_display":"4.08","price_state":"stated","total_value":2856.0,"total_display":"2,856.00","total_whole":"2,856","shares_owned_after":90591.0,"shares_owned_after_display":"90,591","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-16","filed_date":"2017-10-17","scope":"insider"},{"id":4423132,"accession":"0001209191-17-057147","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-057147","line_url":"/filing/0001209191-17-057147#line-1","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586892","owner_name":"Shoemaker Daniel D","owner_display_name":"Shoemaker Daniel D","owner_url":"/insider/0001586892","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12525.0,"shares_display":"12,525","price_per_share":3.86,"price_display":"3.86","price_state":"stated","total_value":48346.5,"total_display":"48,346.50","total_whole":"48,347","shares_owned_after":91291.0,"shares_owned_after_display":"91,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-13","filed_date":"2017-10-17","scope":"insider"},{"id":6714666,"accession":"0001586892-14-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001586892-14-000002","line_url":"/filing/0001586892-14-000002","is_derivative":false,"issuer_cik":"0001434316","issuer_name":"FATE THERAPEUTICS INC","issuer_ticker":"FATE","issuer_name_source":null,"issuer_url":"/issuer/0001434316","owner_cik":"0001586892","owner_name":"Shoemaker Daniel D","owner_display_name":"Shoemaker Daniel D","owner_url":"/insider/0001586892","role":"Officer (Chief Technology Officer)","role_mark":"O","role_mark_label":"Officer (Chief Technology Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Technology Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8653.0,"shares_display":"8,653","price_per_share":9.864896845024846,"price_display":"9.86","price_state":"stated","total_value":85360.9524,"total_display":"85,360.95","total_whole":"85,361","shares_owned_after":26362.0,"shares_owned_after_display":"26,362","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-31","filed_date":"2014-04-02","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":31,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":31,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":31},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001434316","name":"FATE THERAPEUTICS INC","url":"/issuer/0001434316","role":"Officer (Chief Scientific Officer)","n_filings":11,"first_seen":"2014-04-02","last_seen":"2021-03-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001586892","retrieved_at":"2026-08-24T22:35:48+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}